Biofrontera and Kiadis agree to merge; withdrawn
Biofrontera Pharmaceuticals GMBH (drug discovery for nervous system disorders) and Kiadis BV (identifies biologically active compounds) have agreed on a merger of equals. They plan to continue to operate in their respective locations as wholly owned subsidiaries of a new holding company, Aliga Pharmaceuticals AG.
Drug Discovery Tools
- Natural Products
- Drug Discovery Tools
- Full Acquisition
- Intra-Biotech Deal
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com